Skip to content

Breast Cancer Health Center

Drugs Can Cut Breast Cancer Risk for Some: Experts

Draft guidelines for doctors reflect findings, but it's hard to know who will benefit most, experts say
Font Size
A
A
A

continued...

The most important factors for determining risk of developing breast cancer are increased age, family history and having had a biopsy that showed signs of precancers, Nelson said.

One expert said he expected the report to stimulate a new look at this use of these medications.

"These drugs work, this is an effective chemoprevention regimen," said Robert Smith, senior director of cancer screening at the American Cancer Society in Atlanta.

Another reason that these drugs could be underused is that, as women age, they are more likely to see an internist or primary care physician than a gynecologist, and these types of doctors could be less likely to have a conversation about breast cancer chemoprevention, Smith said.

"The task force update is likely to stimulate some action among primary care physicians," Smith said.

Even though patients' concerns about side effects could also factor into the underuse of tamoxifen and raloxifene, most women do decide to take one of the drugs if their doctors recommend it, Smith said. The current report found that 70 percent of women took the recommended treatment dose.

The adverse effects of blood clots, endometrial cancer and cataracts are less likely if women take these drugs at a relatively young age, Nelson said. However, the risks might be too high for women who have a history of blood clots or cataracts, she added.

The reduced risk among young women "really does suggest that the period of time to actively assess risk and consider chemoprevention is not long after menopause" and even as women make the transition into menopause, Smith said.

Although the studies included in this report did not find a decrease in breast cancer mortality, it could be that it will take longer follow-up times to see a difference, Nelson said.

It could also be the fact that these drugs only reduce the risk of a type of breast cancer called hormone receptor-positive breast cancer and that survival is better for this type of breast cancer, Nelson said. Tamoxifen and raloxifene work by interfering with estrogen, which drives the growth of breast cancer in hormone receptor-positive cancers.

1 | 2 | 3

Today on WebMD

Breast Cancer Overview
From self-exams and biopsies to reconstruction, we’ve got you covered.
Dealing with breast cancer
Get answers to your questions.
 
woman having mammogram
Experts don’t agree on all fronts, but you can be your own advocate.
woman undergoing breast cancer test
Many women worry. But the truth? Most abnormalities aren’t breast cancer.
 
Breast Cancer Treatments Improving
VIDEO
Resolved To Quit Smoking
SLIDESHOW
 
Woman getting mammogram
Article
Screening Tests for Women
SLIDESHOW
 
ovarian cancer overview slideshow
SLIDESHOW
serious woman
Article
 
what is your cancer risk
HEALTH CHECK
10 Ways to Revitalize Slideshow
SLIDESHOW